AUTL

AUTOLUS THERAPEUTICS PLC

1.290

-0.040-3.01%

Pre Market: 1.370 +0.080 +6.20%04:01 03/27 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.330/1.330

TODAY RANGE1.280-1.350

VOL96

MARKET CAP343.32M

52 WEEK RANGE1.105-2.700

AVG VOL (3M)1.94M

% TURNOVER0.96%

TURNOVER0

P/E (TTM)-1.5274

% RANGE5.26%

EPS(TTM)-0.8446

P/E(FORWARD)-1.3030

P/B1.390

BVPS1.302

DIVIDEND--

P/S41.80

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP291.84M

SHARES OUTSTANDING266.14M

NEXT EARNINGS03/18-03/23

FREE FLOAT226.23M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·10h ago
Here are the major earnings before the open Friday
NASDAQ·12h ago
Pre-Market Earnings Report for March 27, 2026 : CCL, TMC, CUK, KOPN, SBC, AUTL, SNWV, HUMA, SLE
Seeking Alpha·14h ago
Autolus Therapeutics FY 2025 Earnings Preview
TipRanks·3d ago
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
TipRanks·02/19 07:20
Analysts Are Bullish on Top Healthcare Stocks: Citius Oncology (CTOR), Autolus Therapeutics (AUTL)
Dow Jones·02/17 11:46
Autolus Therapeutics Price Target Announced at $9.00/Share by HC Wainwright & Co.
TipRanks·02/17 11:11
Autolus Therapeutics initiated with a Buy at H.C. Wainwright
TipRanks·02/13 11:43
Autolus Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
TipRanks·02/04 14:01
Autolus Therapeutics reports inducement grants under Nasdaq listing rule
TipRanks·01/26 21:32
Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement
TipRanks·01/17 14:26
Wells Fargo Keeps Their Buy Rating on Autolus Therapeutics (AUTL)
TipRanks·01/13 14:02
Autolus Therapeutics price target lowered to $8 from $10 at Truist
TipRanks·01/13 13:38
Truist Financial Sticks to Its Buy Rating for Autolus Therapeutics (AUTL)
TipRanks·01/13 02:46
Maintaining Buy on Autolus: Solid Aucatzyl Growth and Extended Cash Runway Support Attractive Risk‑Reward Despite Lowered Targets
TipRanks·01/12 16:55
Autolus Therapeutics price target lowered to $10 from $11 at Needham

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-1.00%

877.01

Biogen Inc

BIIB

+1.20%

183.64

Amgen Inc

AMGN

-0.61%

347.80

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+28.91%

0.1418

Lilly Eli & Co

LLY

-1.18%

906.70

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

+0.45%

2.240

Johnson & Johnson

JNJ

-0.94%

235.37

ABBV

Zoetis Inc

ZTS

-0.28%

115.67

Gilead Sciences Inc

GILD

+0.56%

138.11

NVO

Bristol-Myers Squibb Co

BMY

-1.08%

57.48

Alexion Pharms

ALXN

0.00%

182.50

Pfizer

PFE

-1.61%

26.97

Sanofi FR

SNY

-1.63%

44.60

GCVRZ

Novartis

NVS

+0.35%

148.61

Dr Reddys Labs

RDY

-1.61%

13.47

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.